Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases

Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases

US Patent 12083163 · Granted Sep 10, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapy2025
Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapy2025
Anti-human CD45RC antibodies and uses thereof2024
Anti-human CD45RC antibodies and uses thereof2024
Methods for obtaining regulatory t cells and uses thereof2024
Methods for obtaining regulatory t cells and uses thereof2024
Methods for obtaining regulatory t cells and uses thereof2024
Method for obtaining T cells from pluripotent stem cells, and uses thereof2024
Pharmaceutical composition comprising IL-34 and a mTOR inhibitor2021
Pharmaceutical composition comprising IL-34 and a mTOR inhibitor2021
Pharmaceutical composition comprising IL-34 and a mTOR inhibitor2021
Methods for obtaining regulatory T cells and uses thereof2020